Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

26.10.2022 | original article

Evaluation of Tp-e interval and Tp-e/QTc ratio in patients with inflammatory bowel disease

verfasst von: MD İbrahim Ethem Güven, MD Mustafa Candemir, MD Batuhan Başpınar, MD Rasim Eren Cankurtaran, MD Professor Ertuğrul Kayaçetin

Erschienen in: Wiener klinische Wochenschrift

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background

Inflammatory bowel disease (IBD), a multisystemic inflammatory disorder, has been associated with increased risk of cardiovascular problems, including complications such as conduction defects and arrhythmias. Therefore, the early assessment of the risk factors predisposing to ventricular arrhythmias is crucial, since it can improve clinical outcomes. The objective of the present study is to evaluate ventricular repolarization by using Tp‑e interval and Tp-e/QTc ratio as candidate markers of ventricular arrhythmias in patients with IBD.

Methods

The presented study was designed as a single-center prospective cohort study. The study population consisted of 175 patients with IBD and 175 healthy volunteers. The Tp‑e interval, corrected QT (QTc), and Tp-e/QTc ratio were measured from the 12-lead electrocardiogram. These parameters were compared between groups.

Results

The groups were similar in terms of electrocardiographic findings such as heart rate, QRS interval, and QTc interval. However, Tp‑e interval (87.0 ms, interquartile range, IQR 81.0–105.0 ms vs. 84.0 ms, IQR 74.0–92.0 ms; p < 0.001) and Tp-e/QTc ratio (0.21 ± 0.04 vs. 0.19 ± 0.05; p < 0.001) were significantly increased in IBD patient group compared to control group. Notably, a positive correlation was demonstrated between Tp‑e interval, Tp-e/QTc ratio and disease duration (Spearman’s Rho = 0.36, p < 0.001 for Tp‑e; Spearman’s Rho = 0.28, p < 0.001 for Tp-e/QTc).

Conclusion

This study demonstrated that IBD patients are at increased risk of disrupted ventricular repolarization (increased Tpe, Tpe/QTc ratio). In addition, a positive correlation was demonstrated between Tp‑e interval, Tp-e/QTc ratio, and disease duration. Therefore, IBD patients, especially those with long-standing diseases, should be more closely screened for ventricular arrhythmias.
Literatur
2.
Zurück zum Zitat Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427–34. CrossRefPubMed Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427–34. CrossRefPubMed
3.
Zurück zum Zitat Vavricka SR, Schoepfer A, Scharl M, et al. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1982–92. CrossRefPubMed Vavricka SR, Schoepfer A, Scharl M, et al. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1982–92. CrossRefPubMed
4.
Zurück zum Zitat Bunu DM, Timofte CE, Ciocoiu M, et al. Cardiovascular manifestations of inflammatory bowel disease: pathogenesis, diagnosis, and preventive strategies. Gastroenterol Res Pract. 2019;2019:3012509. CrossRefPubMedPubMedCentral Bunu DM, Timofte CE, Ciocoiu M, et al. Cardiovascular manifestations of inflammatory bowel disease: pathogenesis, diagnosis, and preventive strategies. Gastroenterol Res Pract. 2019;2019:3012509. CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Lewek J, Kaczmarek K, Cygankiewicz I, et al. Inflammation and arrhythmias: potential mechanisms and clinical implications. Expert Rev Cardiovasc Ther. 2014;12:1077–85. CrossRefPubMed Lewek J, Kaczmarek K, Cygankiewicz I, et al. Inflammation and arrhythmias: potential mechanisms and clinical implications. Expert Rev Cardiovasc Ther. 2014;12:1077–85. CrossRefPubMed
6.
Zurück zum Zitat Castro-Torres Y, Carmona-Puerta R, Katholi RE. Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice. World J Clin Cases. 2015;3:705–20. CrossRefPubMedPubMedCentral Castro-Torres Y, Carmona-Puerta R, Katholi RE. Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice. World J Clin Cases. 2015;3:705–20. CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Acar G, Yorgun H, Inci MF, et al. Evaluation of Tp‑e interval and Tp-e/QT ratio in patients with ankylosing spondylitis. Mod Rheumatol. 2014;24:327–30. CrossRefPubMed Acar G, Yorgun H, Inci MF, et al. Evaluation of Tp‑e interval and Tp-e/QT ratio in patients with ankylosing spondylitis. Mod Rheumatol. 2014;24:327–30. CrossRefPubMed
8.
Zurück zum Zitat Acar GR, Akkoyun M, Nacar AB, et al. Evaluation of Tp‑e interval and Tp-e/QT ratio in patients with rheumatoid arthritis. Turk Kardiyol Dern Ars. 2014;42:29–34. CrossRefPubMed Acar GR, Akkoyun M, Nacar AB, et al. Evaluation of Tp‑e interval and Tp-e/QT ratio in patients with rheumatoid arthritis. Turk Kardiyol Dern Ars. 2014;42:29–34. CrossRefPubMed
9.
Zurück zum Zitat Hidayet Ş, Demir V, Turan Y, et al. Evaluation of Tp‑e interval, Tp-e/QT ratio, and Tp-e/QTc ratio in patients with Behçet’s disease. Anatol J Cardiol. 2019;22:85–90. PubMedPubMedCentral Hidayet Ş, Demir V, Turan Y, et al. Evaluation of Tp‑e interval, Tp-e/QT ratio, and Tp-e/QTc ratio in patients with Behçet’s disease. Anatol J Cardiol. 2019;22:85–90. PubMedPubMedCentral
10.
Zurück zum Zitat Ott C, Schölmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10:585–95. CrossRefPubMed Ott C, Schölmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10:585–95. CrossRefPubMed
11.
Zurück zum Zitat Danese S, Semeraro S, Papa A, et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005;11:7227–36. CrossRefPubMedPubMedCentral Danese S, Semeraro S, Papa A, et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005;11:7227–36. CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Harbord M, Annese V, Vavricka SR, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10:239–54. CrossRefPubMed Harbord M, Annese V, Vavricka SR, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10:239–54. CrossRefPubMed
13.
Zurück zum Zitat Patel RS, Rohit Reddy S, Llukmani A, et al. Cardiovascular manifestations in inflammatory bowel disease: a systematic review of the pathogenesis and management of pericarditis. Cureus. 2021;13:e14010. PubMedPubMedCentral Patel RS, Rohit Reddy S, Llukmani A, et al. Cardiovascular manifestations in inflammatory bowel disease: a systematic review of the pathogenesis and management of pericarditis. Cureus. 2021;13:e14010. PubMedPubMedCentral
14.
Zurück zum Zitat Greuter T, Rieder F, Kucharzik T, et al. Emerging treatment options for extraintestinal manifestations in IBD. Gut. 2021;70:796–802. CrossRefPubMed Greuter T, Rieder F, Kucharzik T, et al. Emerging treatment options for extraintestinal manifestations in IBD. Gut. 2021;70:796–802. CrossRefPubMed
15.
Zurück zum Zitat Nevulis MG, Baker C, Lebovics E, et al. Overview of link between inflammatory bowel disease and cardiovascular disease. Cardiol Rev. 2018;26:287–93. CrossRefPubMed Nevulis MG, Baker C, Lebovics E, et al. Overview of link between inflammatory bowel disease and cardiovascular disease. Cardiol Rev. 2018;26:287–93. CrossRefPubMed
16.
Zurück zum Zitat Singh S, Singh H, Loftus EV, et al. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:382–93. CrossRefPubMed Singh S, Singh H, Loftus EV, et al. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:382–93. CrossRefPubMed
17.
Zurück zum Zitat Karmiris K, Avgerinos A, Tavernaraki A, et al. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. J Crohns Colitis. 2016;10:429–36. CrossRefPubMed Karmiris K, Avgerinos A, Tavernaraki A, et al. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. J Crohns Colitis. 2016;10:429–36. CrossRefPubMed
18.
Zurück zum Zitat Mitchell NE, Harrison N, Junga Z, et al. Heart under attack: cardiac manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2018;24:2322–6. CrossRefPubMed Mitchell NE, Harrison N, Junga Z, et al. Heart under attack: cardiac manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2018;24:2322–6. CrossRefPubMed
19.
Zurück zum Zitat Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 2016;29:277–314. CrossRefPubMed Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 2016;29:277–314. CrossRefPubMed
20.
Zurück zum Zitat Rungoe C, Nyboe Andersen N, Jess T. Inflammatory bowel disease and risk of coronary heart disease. Trends Cardiovasc Med. 2015;25:699–704. CrossRefPubMed Rungoe C, Nyboe Andersen N, Jess T. Inflammatory bowel disease and risk of coronary heart disease. Trends Cardiovasc Med. 2015;25:699–704. CrossRefPubMed
21.
Zurück zum Zitat Zanoli L, Rastelli S, Granata A, et al. Arterial stiffness in inflammatory bowel disease: a systematic review and meta-analysis. J Hypertens. 2016;34:822–9. CrossRefPubMed Zanoli L, Rastelli S, Granata A, et al. Arterial stiffness in inflammatory bowel disease: a systematic review and meta-analysis. J Hypertens. 2016;34:822–9. CrossRefPubMed
22.
23.
Zurück zum Zitat Tan VP, Chung A, Yan BP, Gibson PR. Venous and arterial disease in inflammatory bowel disease. J Gastroenterol Hepatol. 2013;28:1095–113. CrossRefPubMed Tan VP, Chung A, Yan BP, Gibson PR. Venous and arterial disease in inflammatory bowel disease. J Gastroenterol Hepatol. 2013;28:1095–113. CrossRefPubMed
24.
Zurück zum Zitat Engel T, Ben-Horin S, Beer-Gabel M. Autonomic dysfunction correlates with clinical and inflammatory activity in patients with Crohn’s disease. Inflamm Bowel Dis. 2015;21:2320–6. PubMed Engel T, Ben-Horin S, Beer-Gabel M. Autonomic dysfunction correlates with clinical and inflammatory activity in patients with Crohn’s disease. Inflamm Bowel Dis. 2015;21:2320–6. PubMed
25.
Zurück zum Zitat Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol. 2017;2018(72):e91–e220. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol. 2017;2018(72):e91–e220.
27.
Zurück zum Zitat Erikssen G, Liestøl K, Gullestad L, et al. The terminal part of the QT interval (T peak to T end): a predictor of mortality after acute myocardial infarction. Ann Noninvasive Electrocardiol. 2012;17:85–94. CrossRefPubMedPubMedCentral Erikssen G, Liestøl K, Gullestad L, et al. The terminal part of the QT interval (T peak to T end): a predictor of mortality after acute myocardial infarction. Ann Noninvasive Electrocardiol. 2012;17:85–94. CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Gupta P, Patel C, Patel H, et al. T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol. 2008;41:567–74. CrossRefPubMed Gupta P, Patel C, Patel H, et al. T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol. 2008;41:567–74. CrossRefPubMed
29.
Zurück zum Zitat Zhao X, Xie Z, Chu Y, et al. Association between Tp-e/QT ratio and prognosis in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Clin Cardiol. 2012;35:559–64. CrossRefPubMedPubMedCentral Zhao X, Xie Z, Chu Y, et al. Association between Tp-e/QT ratio and prognosis in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Clin Cardiol. 2012;35:559–64. CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Candemir M, Candemir B, Ertürk A. Evaluation of cardiac autonomic nervous system in patients with ankylosing spondylitis using 12-lead electrocardiography and Holter monitoring. Clin Rheumatol. 2020;39:2631–9. CrossRefPubMed Candemir M, Candemir B, Ertürk A. Evaluation of cardiac autonomic nervous system in patients with ankylosing spondylitis using 12-lead electrocardiography and Holter monitoring. Clin Rheumatol. 2020;39:2631–9. CrossRefPubMed
Metadaten
Titel
Evaluation of Tp-e interval and Tp-e/QTc ratio in patients with inflammatory bowel disease
verfasst von
MD İbrahim Ethem Güven
MD Mustafa Candemir
MD Batuhan Başpınar
MD Rasim Eren Cankurtaran
MD Professor Ertuğrul Kayaçetin
Publikationsdatum
26.10.2022
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-022-02100-4